Baker Bros. Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.28M | Sell |
|
|||||
|
2024
Q1 | $17M | Sell |
|
|||||
|
2023
Q4 | $8.7M | Hold |
|
|||||
|
2023
Q3 | $8.56M | Hold |
|
|||||
|
2023
Q2 | $10.1M | Buy |
|
|||||
|
2023
Q1 | $10.7M | Hold |
|
|||||
|
2022
Q4 | $14.4M | Hold |
|
|||||
|
2022
Q3 | $10.6M | Hold |
|
|||||
|
2022
Q2 | $16.7M | Hold |
|
|||||
|
2022
Q1 | $20.3M | Hold |
|
|||||
|
2021
Q4 | $36.9M | Hold |
|
|||||
|
2021
Q3 | $50.8M | Hold |
|
|||||
|
2021
Q2 | $41.9M | Hold |
|
|||||
|
2021
Q1 | $52.2M | Hold |
|
|||||
|
2020
Q4 | $53M | Buy |
|
|||||
|
2020
Q3 | $50.5M | Sell |
|
|||||
|
2020
Q2 | $66.8M | Buy |
|
|||||
|
2020
Q1 | $10M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.19M | Hold |
|
|||||
|
2018
Q1 | $1.12M | Hold |
|
|||||
|
2017
Q4 | $668K | Hold |
|
|||||
|
2017
Q3 | $819K | Hold |
|
|||||
|
2017
Q2 | $449K | Hold |
|
|||||
|
2017
Q1 | $551K | Hold |
|
|||||
|
2016
Q4 | $405K | Hold |
|
|||||
|
2016
Q3 | $705K | Hold |
|
|||||
|
2016
Q2 | $815K | Hold |
|
|||||
|
2016
Q1 | $813K | Hold |
|
|||||
|
2015
Q4 | $1.21M | Hold |
|
|||||
|
2015
Q3 | $1.2M | Hold |
|
|||||
|
2015
Q2 | $1.83M | Buy |
|